We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
First Financial Bancorp
FFBC
$3.55B
| $3K | ﹤0.01% |
+198
| New | +$3.11K |
|
1552
FNB Corp
FNB
$6.73B
| $3K | ﹤0.01% |
+276
| New | +$2.34K |
|
1553
Fox Factory Holding Corp
FOXF
$755M
| $3K | ﹤0.01% |
+31
| New | +$2.82K |
|
1554
Goodyear
GT
$2B
| $3K | ﹤0.01% |
+285
| New | +$2.87K |
|
1555
Heritage Financial
HFWA
$1.22B
| $3K | ﹤0.01% |
+145
| New | +$3.26K |
|
1556
Howard Hughes
HHH
$3.81B
| $3K | ﹤0.01% |
+43
| New | +$2.88K |
|
1557
Honda
HMC
$39.1B
| $3K | ﹤0.01% |
+98
| New | +$2.65K |
|
1558
HSBC
HSBC
$365B
| $3K | ﹤0.01% |
+115
| New | +$2.73K |
|
1559
Hancock Whitney
HWC
$6.2B
| $3K | ﹤0.01% |
+86
| New | +$2.32K |
|
|
PPLI
1560
People Inc
PPLI
$3.09B
| $3K | ﹤0.01% |
+33
| New | +$2.53K |
|
1561
Integra LifeSciences
IART
$1.29B
| $3K | ﹤0.01% |
+52
| New | +$2.8K |
|
1562
Independent Bank
INDB
$3.99B
| $3K | ﹤0.01% |
+45
| New | +$2.92K |
|
1563
ING
ING
$99.8B
| $3K | ﹤0.01% |
+336
| New | +$2.88K |
|
1564
Keurig Dr Pepper
KDP
$42.3B
| $3K | ﹤0.01% |
+103
| New | +$3.05K |
|
|
KREF
1565
KKR Real Estate Finance Trust
KREF
$448M
| $3K | ﹤0.01% |
+192
| New | +$3.39K |
|
1566
Lemonade
LMND
$3.74B
| $3K | ﹤0.01% |
+23
| New | +$1.7K |
|
1567
Louisiana-Pacific
LPX
$5.06B
| $3K | ﹤0.01% |
+85
| New | +$2.85K |
|
1568
Mizuho Financial
MFG
$127B
| $3K | ﹤0.01% |
+1,190
| New | +$3.07K |
|
1569
Melco Resorts & Entertainment
MLCO
$2.22B
| $3K | ﹤0.01% |
+151
| New | +$2.63K |
|
1570
Marvell Technology
MRVL
$168B
| $3K | ﹤0.01% |
+68
| New | +$2.94K |
|
1571
Match Group
MTCH
$9.19B
| $3K | ﹤0.01% |
+18
| New | +$2.38K |
|
1572
Minerals Technologies
MTX
$2.36B
| $3K | ﹤0.01% |
+46
| New | +$2.73K |
|
1573
Mitsubishi UFJ Financial
MUFG
$253B
| $3K | ﹤0.01% |
+711
| New | +$3.02K |
|
1574
Neogen
NEOG
$2.63B
| $3K | ﹤0.01% |
+68
| New | +$2.53K |
|
1575
NewMarket
NEU
$7.82B
| $3K | ﹤0.01% |
+7
| New | +$2.61K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.